Since the first monoclonal antibody drug, muromonab-CD3, was approved for marketing in
1986, 165 antibody drugs have been approved or are under regulatory review worldwide …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to significant changes
in life and healthcare all over the world. Pregnant women and their newborns require extra …

Abstract The coronavirus disease 2019 (COVID-19) in pregnancy causes adverse outcomes
for both the mother and the fetus. Neonates are at risk of vertical transmission and in-utero …

COVID-19 in pregnant women increases the risk of adverse pregnancy outcomes, including
preeclampsia. This meta-analysis aimed to examine the effect of SARS-CoV-2 infection on …

During the coronavirus diseases 2019 (COVID-19) pandemic, the safety and efficacy of
vaccination during pregnancy, particularly regarding the risk of preterm birth, have been a …

The impact of post-acute sequelae of SARS-CoV-2 infection, or Long coronavirus disease
2019 (COVID-19), on pregnant women remains a growing concern. The present systematic …

The impact of post-acute sequelae of SARS-CoV-2 infection, or Long coronavirus disease
2019 (COVID-19), on pregnant women remains a growing concern. The present systematic …

Pregnancy is described as a condition or a state from the time of conception up to the time of
delivery. The 'high-risk'pregnancy means a woman has one or more things that raise her-or …

Background Due to limitations in observational studies, the link between COVID-19 and
adverse pregnancy outcomes (APOs) remains inconclusive. This study uses two-sample …

Background: The COVID-19 pandemic had been uniquely challenging for the general as
well as pregnant and postpartum women. Uncontrollable stress arising due to its high …